Centers for Disease Control and Prevention Injury Control Research Centers and Emergency Medicine

The Centers for Disease Control and Prevention supports eleven extramurally funded Injury Control Research Centers (ICRCs) across the United States. A new cycle of support began in August 2024, with three ICRCs based in academic departments of emergency medicine. Each center has a unique mission focused on injury science, addressing key topics such as community violence, firearm injury, concussion, motor vehicle collisions, and adverse childhood experiences (ACEs). This session will introduce the academic emergency medicine community to the ICRCs. Directors from the University of Pennsylvania, the University of Michigan, and Emory University will share insights on research, training, and outreach opportunities.

Learning Objectives:

Upon completion of this session, participants should be able to:
  • Understand the overall mission and structure of the CDC Injury Prevention Research Program
  • Understand the unique research, training and outreach characteristics of the three ICRCs that are seated within emergency medicine.
  • Understand opportunities available for collaboration and / or training at an ICRC
  • Understand the process for building a new injury center within a department of emergency medicine.

Presenters:

  • Zachary F. Meisel, MD, MPH, MSHP
  • Douglas Wiebe, PhD
  • Jonathan D. Rupp, PhD
Authors
  • zachary meisel

    Zachary F. Meisel, MD, MPH, MSHP

    President-Elect

    University of Pennsylvania Perelman School of Medicine

    Zachary F. Meisel, MD, MPH, MSHP is the Vice Chair for Faculty, the Director of the Center for Emergency Care Policy and Research, and a Professor of Emergency Medicine at the Perelman School of Medicine. Dr. Meisel’s research interests include narrative translation methods, injury prevention, substance use disorder, medical communication, guideline adherence, opioid use disorder, patient safety, emergency medical services, and patient centered comparative effectiveness research. He has a specific focus on using and testing persuasive narratives to promote evidence translation to patients, providers, and policy makers. Dr. Meisel studies ways to improve the translation of research evidence, particularly around prescription opioids. He is also co-director and outreach lead for the Penn Injury Science Center (PISC), a CDC-funded Center of Excellence. He is the principal investigator of the Life STORRIED study (Life Stories for Opioid Risk Reduction in the Emergency Department), a multiyear, multicenter Patient Centered Outcomes Research Institute (PCORI) funded clinical trial focusing on the comparative effectiveness of probabilistic versus patient narrative enhanced risk communication for pain management following emergency care.

    He is also the multiple PI (mpi) of a CDC RO1 focused, in partnership with the City of Philadelphia, on evaluation of an overdose ambulance and blight remediation. He also directs the Policy and Dissemination core for the NIH/NIDA-funded Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (CHERISH). He has served as principal investigator or co-PI of major grants from the Agency for Healthcare Research and Quality (AHRQ) and the WT Grant Foundation, focused on the translation of evidence to providers and patients. He has received over 11 million dollars in extramural funding as PI or co-PI. He has been continuously funded from the NIH, CDC, AHRQ or PCORI since 2013. Dr. Meisel has been a medical columnist for Slate and Time with expertise in dissemination translation of health services research results for audiences such as patients and policy makers. He is Senior Associate Editor for Health Communication for the journal Academic Emergency Medicine. He has published in medical journals such as JAMA, Health Affairs, Annals of Emergency Medicine, Obstetrics and Gynecology, and BMJ.

  • Douglas Wiebe, PhD

    University of Michigan

    Dr. Wiebe is a Professor at the University of Michigan with appointments in the Department of Emergency Medicine and the Department of Epidemiology (School of Public Health). He is Director of the U-M Injury Prevention Center, one of 11 centers funded by the CDC, and is PI of the Ivy League-Big Ten Epidemiology of Concussion Study.

  • Jonathan D. Rupp, PhD

    Emory University

    Dr. Jonathan Rupp is the Vice Chair for Innovation and Discovery, and a Professor in Emory University School of Medicine's Department of Emergency Medicine. He holds a secondary appointment as a Professor in the Gangarosa Department of Environmental Health at Emory's Rollins School of Public Health, and an Adjunct Research Professor appointment at the University of Michigan Transportation Research Institute in the UofM College of Engineering. Dr. Rupp’s role at IPRCE involves providing administrative, scientific, and financial oversight of the Center, including its daily functioning, progress towards the center’s mission and specific aims, management of IPRCE faculty leading each Core, and funding Center initiatives and pilot grants. Dr. Rupp provides vision and guidance for the Center’s Outreach, Research, and Training activities and our Task Forces. He represents the Center in communications with external partners and stakeholders. He also chairs the Steering Committee and the Task Force Leaders Committee.

    Dr. Rupp has been extramurally funded for over 20 years. His past research has supported the development of new federal regulations, test procedures, and test devices to improve safety for occupants in motor vehicle crashes and in military vehicle exposed to under-body blast. He has collected and analyzed data on crashes and crash injury to identify risk and protective factors, developing tools for assessing the ability of vehicles to mitigate the potential for injury crashes, and statistical modeling to estimate the benefits of injury prevention technologies. His current work includes studies aimed at developing new methods for investigating pedestrian injury crashes, assessing how to most effectively counsel patients on firearm injury prevention in the ED, and characterizing factors influencing micro mobility device injuries.

    He also is a member of the Georgia Crash Outcomes Data Evaluation System (CODES) Board of Directors, the Georgia Violent Death Reporting System’s Advisory Committee, the Rollins—Spark (Program on Substance Use Disorders) Advisory Board, the Georgia State University Center for Alcohol and Violence Research External Advisory Board, and the University of North Carolina Injury Prevention Research Center External Advisory Board.

Related Media